Novartis has confirmed reports by Swiss daily newspaper Tages-Anzeiger that it plans to slash 8,000 jobs worldwide.
Swiss drugmaker Novartis has made a five-year financial commitment of $250 million to fight neglected tropical diseases (NTDs) and malaria.
In the their first-ever collaboration, South Korea’s Samsung Biologics and Switzerland’s Novartis have inked an initial $81 million contract manufacturing and development...
Novartis subsidiary Sandoz has launched a generic version of Combigan, the ocular hypertensiondrug made by AbbVie’s Allergan arm. The copy of the off-patent eye drops...
What does 2022 hold for the biopharma industry? Which companies can play at the forefront in terms of products as well as business? Covid-19 will continue to be a...
Swiss pharma powerhouse Novartis is merging its pharmaceuticals and oncology businesses into a new unit called Innovative Medicines (IM). The restructuring that will...
Swiss pharma Novartis has acquired Gyroscope Therapeutics, a clinical-stage gene therapy company focused on diseases of the eye, from Syncona, a UK-based firm that says...
US private equity firms Blackstone and Carlyle may make a joint offer for the Novartis generics unit Sandoz, Bloomberg reports. With six other possible bidders seen as...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | Twitter